Table 1 Baseline patient characteristics
N | Percentage or range | |
|---|---|---|
Total patients | 70 | 100 |
Male | 41 | 59 |
Female | 29 | 41 |
Age (median) | 63 years | 29–77 |
ECOG Performance Status 0 | 38 | 54 |
ECOG Performance Status 1 | 29 | 41 |
ECOG Performance Status 2 | 3 | 4 |
Disease site—bowel | 58 | 83 |
Disease site—liver | 58 | 83 |
Disease site—lung | 25 | 36 |
Disease site—lymph nodes | 24 | 34 |
Disease site—bone | 1 | 1 |
Disease site—other | 10 | 14 |
1 metastatic site | 31 | 45 |
2 metastatic sites | 26 | 37 |
3 + metastatic sites | 13 | 18 |
Well differentiated tumor | 7 | 10 |
Moderately differentiated tumor | 45 | 64 |
Poorly differentiated tumor | 9 | 13 |
Unknown degree of differentiation | 9 | 13 |
Primary tumor in situ—yes | 22 | 31 |
Primary tumor in situ—no | 48 | 69 |
Platelets (normal range 150–400) | 373 | 172–931 × 109/L |
LDH (normal range < 450) | 475 | 157–9335 IU/L |
CEA (normal range < 5) | 47 | <3–16,485 IU/L |